These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7544768)

  • 1. TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
    Elliott MJ; Feldmann M; Maini RN
    Int J Immunopharmacol; 1995 Feb; 17(2):141-5. PubMed ID: 7544768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
    Maini RN; Elliott MJ; Brennan FM; Williams RO; Chu CQ; Paleolog E; Charles PJ; Taylor PC; Feldmann M
    Immunol Rev; 1995 Apr; 144():195-223. PubMed ID: 7590814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibody therapy for rheumatoid arthritis].
    Ishii T; Saeki Y
    Nihon Rinsho; 2002 Mar; 60(3):551-5. PubMed ID: 11904972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
    J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TNF alpha for the therapy of rheumatoid arthritis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S63-6. PubMed ID: 7768056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA).
    Maini RN; Elliott MJ; Brennan FM; Feldmann M
    Clin Exp Immunol; 1995 Aug; 101(2):207-12. PubMed ID: 7648705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis.
    Paleolog E
    Mol Pathol; 1997 Oct; 50(5):225-33. PubMed ID: 9497911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF alpha is an effective therapeutic target for rheumatoid arthritis.
    Feldmann M; Brennan FM; Elliott MJ; Williams RO; Maini RN
    Ann N Y Acad Sci; 1995 Sep; 766():272-8. PubMed ID: 7486670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of anti-TNF therapy for rheumatoid arthritis.
    Feldmann M
    Nat Rev Immunol; 2002 May; 2(5):364-71. PubMed ID: 12033742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis.
    Kavanaugh AF
    Rheum Dis Clin North Am; 1998 Aug; 24(3):593-614. PubMed ID: 9710889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.
    Camussi G; Lupia E
    Drugs; 1998 May; 55(5):613-20. PubMed ID: 9585859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
    Feldmann M; Brennan FM; Williams RO; Elliott MJ; Maini RN
    J Inflamm; 1995-1996; 47(1-2):90-6. PubMed ID: 8913935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
    Maini RN; Brennan FM; Williams R; Chu CQ; Cope AP; Gibbons D; Elliott M; Feldmann M
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S173-5. PubMed ID: 8391952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
    Mugnier B; Bouvenot G
    Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of tumor necrosis factor (TNF-alpha) in rheumatoid arthritis].
    Godyń-Swedzioł RM; Stańczyk J; Hilt J; Kowalski ML
    Przegl Lek; 2004; 61(2):90-3. PubMed ID: 15230148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
    Feldmann M
    Int Arch Allergy Immunol; 1996 Dec; 111(4):362-5. PubMed ID: 8957109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    APMIS; 1997 Apr; 105(4):257-63. PubMed ID: 9164467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.